Consolidated Statements of Operations and Comprehensive Loss - USD ($) shares in Thousands, $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2018 |
Jun. 30, 2017 |
Jun. 30, 2018 |
Jun. 30, 2017 |
|
| Net sales | ||||
| Total net sales | $ 170,236 | $ 169,990 | $ 324,069 | $ 333,152 |
| Cost of sales | ||||
| Total cost of sales | 86,589 | 86,598 | 164,772 | 172,880 |
| Gross profit | 83,647 | 83,392 | 159,297 | 160,272 |
| Operating expenses | ||||
| Research and development, net | 23,689 | 23,251 | 48,799 | 47,885 |
| Selling, general and administrative | 61,887 | 65,186 | 118,892 | 130,061 |
| Total operating expenses | 85,576 | 88,437 | 167,691 | 177,946 |
| Operating loss | (1,929) | (5,045) | (8,394) | (17,674) |
| Financial income (expense), net | (83) | 429 | (75) | 685 |
| Loss before income taxes | (2,012) | (4,616) | (8,469) | (16,989) |
| Income tax expenses | 205 | 1,308 | 806 | 2,634 |
| Share in losses of associated companies | (1,360) | (229) | (7,433) | (517) |
| Net loss | (3,577) | (6,153) | (16,708) | (20,140) |
| Net loss attributable to non-controlling interests | (26) | (166) | (116) | (296) |
| Net loss attributable to Stratasys Ltd. | $ (3,551) | $ (5,987) | $ (16,592) | $ (19,844) |
| Net loss per ordinary share attributable to Stratasys Ltd. - basic and diluted | $ (0.08) | $ (0.11) | $ (0.33) | $ (0.38) |
| Weighted average ordinary shares outstanding - basic and diluted | 53,722 | 52,778 | 53,689 | 52,733 |
| Comprehensive loss | ||||
| Net loss | $ (3,577) | $ (6,153) | $ (16,708) | $ (20,140) |
| Other comprehensive income, net of tax: | ||||
| Foreign currency translation adjustments | (3,222) | 2,437 | (1,211) | 3,150 |
| Unrealized gains (losses) on derivatives designated as cash flow hedges | (544) | (337) | (869) | 186 |
| Other comprehensive income (loss), net of tax | (3,766) | 2,100 | (2,080) | 3,336 |
| Comprehensive loss | (7,343) | (4,053) | (18,788) | (16,804) |
| Less: comprehensive loss attributable to non-controlling interests | (26) | (166) | (116) | (296) |
| Comprehensive loss attributable to Stratasys Ltd. | (7,317) | (3,887) | (18,672) | (16,508) |
| Products [Member] | ||||
| Net sales | ||||
| Total net sales | 118,403 | 121,021 | 222,320 | 236,108 |
| Cost of sales | ||||
| Total cost of sales | 53,262 | 54,723 | 98,480 | 109,203 |
| Services [Member] | ||||
| Net sales | ||||
| Total net sales | 51,833 | 48,969 | 101,749 | 97,044 |
| Cost of sales | ||||
| Total cost of sales | $ 33,327 | $ 31,875 | $ 66,292 | $ 63,677 |
| X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
- Definition Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after tax of other comprehensive income (loss) attributable to parent entity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|